Non-melanoma skin cancer outcomes in kidney transplant recipients converted from calcineurin inhibitors to mTOR inhibitors: a systematic review

Renal transplant recipients treated with calcineurin inhibitors (CNIs) are at a high risk of developing a skin cancer. Therefore, new therapeutic options such as inhibitors of the mammalian target of rapamycin (mTORi) have been studied to find treatment regimens decreasing the rate of skin cancers....

Descripción completa

Detalles Bibliográficos
Autores principales: Olszewska, Berenika, Imko-Walczuk, Beata, Dębska-Ślizień, Alicja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2023
Materias:
Review Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258712/
https://www.ncbi.nlm.nih.gov/pubmed/37312910
http://dx.doi.org/10.5114/ada.2023.127637

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258712/
https://www.ncbi.nlm.nih.gov/pubmed/37312910
http://dx.doi.org/10.5114/ada.2023.127637

Ejemplares similares